MDA Caps – 100mg (“Sally”)
MDA Caps – 100mg (often referred to by the street name “Sally” or “Sass”) contain 100 milligrams of crystalline or powdered MDA (3,4-Methylenedioxyamphetamine) encapsulated in gelatin or vegetarian capsules.
While related to MDMA (“Molly” or “Ecstasy”), MDA is a distinct synthetic compound known for its stronger psychedelic effects, longer duration, and higher relative toxicity.
1. Pharmacology: MDA vs. MDMA
MDA acts as a powerful central nervous system (CNS) stimulant, entactogen, and psychedelic by triggering the release of serotonin, dopamine, and norepinephrine while directly stimulating $5\text{-HT}_{2\text{A}}$ receptors.
[Comparative Pharmacological Profile]
Property MDMA ("Molly") MDA ("Sally")
─────────── ────────────── ───────────────
Primary Feel : Empathy, Warmth, Energy Visuals, Euphoria, Psychedelic
Duration : 3 to 5 Hours 6 to 8+ Hours
Sassafras/Sass : Precursor Metabolite Direct Precursor / Crude Extract
$5\text{-HT}_{2\text{A}}$ Binding: Low (Mild visuals) High (Clear open/closed-eye visuals)
-
Potency Differential: MDA is substantially more potent than MDMA per milligram. A 100mg dose of MDA produces a significantly stronger physiological and mental load than 100mg of MDMA.
-
Duration: The active phase of MDA lasts 6 to 8 hours (with residual stimulation lasting up to 12 hours), compared to MDMA’s typical 3 to 5 hour arc.
2. Dosage Dynamics & Experience Profile
Because MDA has a steep dose-response curve, accurate milligram measurements inside capsules are critical. Unregulated street capsules carry high variance in actual fill weight and purity.
| Dosage Level | MDA Milligrams (mg) | Subjective Experience & Physiological Load |
| Threshold | 30 mg – 50 mg | Mild mood lift, subtle physical energy, light pupil dilation. |
| Standard Dose | 70 mg – 100 mg | Strong euphoria, enhanced empathy, pronounced open/closed-eye visuals, heightened sensory awareness. |
| High Dose | 100 mg – 150 mg+ | Intense visual hallucinations, strong jaw clenching (bruxism), eye wiggles (nystagmus), heavy body load. |
| Overdose / Toxic | 150 mg+ | Severe hyperthermia, confusion, panic, cardiovascular strain, muscle rigidity, and risk of seizures. |
3. Physical & Neurological Risks
MDA carries a higher risk of neurotoxicity and hyperthermia compared to MDMA:
-
Elevated Neurotoxicity: MDA metabolites are directly toxic to serotonergic neurons. Studies indicate MDA is significantly more neurotoxic than MDMA, requiring longer recovery periods between exposures.
-
Hyperthermia & Dehydration: MDA severely impairs central thermoregulation. Physical exertion (e.g., dancing) in warm environments can drive body temperature to dangerous levels (>40°C / 104°F), risking acute heatstroke and organ failure.
-
Severe Comedown: Due to deeper serotonin depletion, the “comedown” phase over subsequent days often includes acute low mood, anxiety, irritability, and severe fatigue.
4. Harm Reduction & Safety Protocols
Health agencies and harm-reduction advocates emphasize the following protocols for encapsulated psychoactives:
-
Test Before Consuming: “Sass” or “Sally” capsules frequently contain crude manufacturing byproducts, synthetic cathinones, or methamphetamine. Use multi-reagent test kits (Marquis, Froehde, and Simon’s) to verify contents.
-
Note: Simon’s reagent turns blue for MDMA (secondary amine) but remains clear/colorless for MDA (primary amine), making it essential for distinguishing the two.
-
-
Do Not Dose Like MDMA: Because MDA is more potent, taking a standard MDMA redose (e.g., matching a 100mg–150mg MDMA protocol) can easily push an MDA experience into toxic territory.
-
Avoid Poly-Substance Use: Mixing MDA with alcohol accelerates dehydration, while combining it with prescription antidepressants (SSRIs/MAOIs) or other stimulants drastically increases the risk of fatal Serotonin Syndrome.
-
Hydrate & Cool Down: Sip electrolyte solutions moderately (~250ml/hour resting, ~500ml/hour active) and take regular breaks in cooler, well-ventilated areas.





Reviews
There are no reviews yet.